[News Brief] Akeso’s Ivonescimab Named Key Drug for 2026
Akeso’s bispecific antibody ivonescimab has been included in FirstWord Pharma’s “Spotlight On: The Drugs That Will Shape 2026” list of…
Akeso’s bispecific antibody ivonescimab has been included in FirstWord Pharma’s “Spotlight On: The Drugs That Will Shape 2026” list of…
[Press Release] SINGAPORE – 16 December 2025 -Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has expanded…
The Health Sciences Authority (HSA) has informed healthcare professionals that the prostate cancer drug Xtandi (enzalutamide) can cause falsely elevated…
China’s authorities have approved Enhertu (trastuzumab deruxtecan) as the first HER2-directed antibody-drug conjugate for patients with HER2-positive metastatic gastric cancer.…
Daiichi Sankyo has announced a leadership transition at its Translational Research Centre Europe, with Veronika Müller succeeding Jürgen Müller. This…
The Health Sciences Authority (HSA) has issued a Dear Healthcare Professional Letter to remind clinicians that Cyklokapron (tranexamic acid) injections…
The Health Sciences Authority (HSA) has issued a Dear Healthcare Professional Letter highlighting a newly identified risk associated with the…
Kowa Co., Ltd has announced the launch in Singapore of GLA-ALPHA® Combination Ophthalmic Solution, a new fixed-dose eye drop licensed…
The Asia Summit on Global Health (ASGH) 2026 will be held at the Hong Kong Convention and Exhibition Centre from…
Singapore is reviewing its domestic legal and policy frameworks to align with obligations under the United Nations High Seas Treaty,…